+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin Use Is Associated with Reduced Mortality in Patients with Interstitial Lung Disease



Statin Use Is Associated with Reduced Mortality in Patients with Interstitial Lung Disease



Plos One 10(10): E0140571



We hypothesized that statin use begun before the diagnosis of interstitial lung disease is associated with reduced mortality. We studied all patients diagnosed with interstitial lung disease in the entire Danish population from 1995 through 2009, comparing statin use versus no statin use in a nested 1:2 matched study. The cumulative survival as a function of follow-up time from the date of diagnosis of interstitial lung disease (n = 1,786 + 3,572) and idiopathic lung fibrosis (n = 261 + 522) was higher for statin users versus never users (log-rank: P = 7 · 10(-9) and P = 0.05). The median survival time in patients with interstitial lung disease was 3.3 years in statin users and 2.1 years in never users. Corresponding values in patients with idiopathic lung fibrosis were 3.4 versus 2.4 years. After multivariable adjustment, the hazard ratio for all-cause mortality for statin users versus never users was 0.73 (95% confidence interval, 0.68 to 0.79) in patients with interstitial lung disease and 0.76 (0.62 to 0.93) in patients with idiopathic lung fibrosis. Results were robust in all sensitivity analyses. Among patients with interstitial lung disease statin use was associated with reduced all-cause mortality.

(PDF emailed within 1 workday: $29.90)

Accession: 058900327

Download citation: RISBibTeXText

PMID: 26473476


Related references

Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease mortality, including very elderly patients. Acc Current Journal Review 12(2): 39-40, 2003

Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy. Journal of Cancer 9(11): 2054-2060, 2018

Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients. Journal of the American College of Cardiology 40(10): 1777-1785, November 20, 2002

Preoperative risk factors associated with mortality in lung biopsy patients with interstitial lung disease. Journal of Investigative Surgery 18(1): 39-45, 2005

Mortality Related to Surgical Lung Biopsy in Patients with Interstitial Lung Disease. The Devil Is in the Denominator. American Journal of Respiratory and Critical Care Medicine 193(10): 1082-1084, 2017

Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia. Arthritis and Rheumatism 53(4): 549-557, 2005

Weight loss as a predictor of mortality in patients with interstitial lung disease. European Respiratory Journal 52(3), 2018

Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis. Rheumatology International 37(10): 1735-1745, 2017

Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease. Oncotarget 8(44): 76129-76140, 2017

Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic. Rmd Open 3(1): E000473, 2017

Retrospective analysis of acute exacerbation of interstitial lung diseases with nanoparticle albumin-bound paclitaxel in patients with advanced lung cancer with preexisting interstitial lung disease. Molecular and Clinical Oncology 7(4): 677-680, 2017

Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease. Medical Journal of Australia 186(2): 91-94, 2007

Interstitial lung disease with statin-associated necrotizing autoimmune myopathy responding to rituximab. Archivos de Bronconeumologia 52(7): 395-397, 2018

Predictors of mortality in patients with interstitial lung disease treated with corticosteroids: results from a cohort study. Medicine 93(26): E175, 2015

Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). American Heart Journal 153(4): 573-578, 2007